|
Market Closed -
Hong Kong S.E.
01:38:26 14/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 21.32 HKD | +1.43% |
|
+3.50% | -30.05% |
| 24/09 | Medtide Acquires China Land, Property for Peptide CDMO Project | MT |
| 24/09 | Medtide Inc. Announces Resignation of Li Lingmei as Executive Director, Effective September 24, 2026 | CI |
Company Valuation: Medtide Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 3,884 | 2,580 | - | - |
| Change | - | -33.58% | - | - |
| Enterprise Value (EV) 1 | 3,027 | 2,001 | 1,931 | 1,835 |
| Change | - | -33.9% | -3.5% | -4.96% |
| P/E | - | - | - | - |
| PBR | 2.31x | 1.36x | 1.19x | 1.03x |
| PEG | - | - | - | - |
| Capitalization / Revenue | 6.81x | 4.31x | 3.48x | 2.9x |
| EV / Revenue | 5.31x | 3.34x | 2.6x | 2.06x |
| EV / EBITDA | 12.6x | 8.7x | 6.17x | 4.74x |
| EV / EBIT | 14.2x | 9.72x | 6.94x | 5.39x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | - | - | - |
| Distribution rate | - | - | - | - |
| Net sales 1 | 570.1 | 598.6 | 742.3 | 890.7 |
| EBITDA 1 | 240.2 | 229.9 | 313.1 | 387.5 |
| EBIT 1 | 212.4 | 205.9 | 278.3 | 340.2 |
| Net income | - | - | - | - |
| Net Debt 1 | -857.2 | -578.9 | -649 | -744.7 |
| Reference price 2 | 27.39 | 18.19 | 18.19 | 18.19 |
| Nbr of stocks (in thousands) | 1,41,800 | 1,41,800 | - | - |
| Announcement Date | 30/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 4.01x | 10.45x | -.--% | 38Cr | |
| 20.44x | 7.28x | 14.62x | 1.45% | 7.04TCr | |
| 27.08x | 7.4x | 23.22x | 0.05% | 5.03TCr | |
| 33.03x | 5.94x | 17.79x | 0.98% | 4.75TCr | |
| 33.58x | 3.26x | 14.07x | -.--% | 4.29TCr | |
| -19.54x | 197.56x | -20.76x | -.--% | 4.04TCr | |
| 46.24x | 5.25x | 28.83x | -.--% | 3.97TCr | |
| 26.84x | 7.63x | 19.74x | 0.4% | 3.06TCr | |
| 30.94x | 6.59x | 17.1x | -.--% | 2.68TCr | |
| -13.49x | 4.97x | -6x | -.--% | 2.24TCr | |
| Average | 20.57x | 24.99x | 11.90x | 0.29% | 3.71TCr | |
| Weighted average by Cap. | 22.12x | 26.97x | 13.15x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3880 Stock
- Valuation Medtide Inc.
Select your edition
All financial news and data tailored to specific country editions
